OMEPRAZOLE ZENTIVA LAB 20 mg, gastro-resistant capsule 14 capsules, CIP 3400930181652
Active ingredients: Omeprazole
Commercialized according to BDPMDispensing in France: Prescription only
Gastro-resistant capsule14 capsules, CIP 3400930181652orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- OMEPRAZOLE ZENTIVA LAB 20 mg, gélule gastro-résistante
- Pharmaceutical form
- gélule gastro-résistant(e)
- Route of administration
- orale
- Presentation description
- plaquette(s) polyamide aluminium PVC-Aluminium de 14 gélule(s)
- Marketing authorisation holder
- ZENTIVA FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 31 Jan 2020
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63244391CIP73018165CIP133400930181652Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| OMÉPRAZOLEgélule | 20 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
- 7 capsules, CIP 3400930181591Commercialized according to BDPM
- 14 capsules, CIP 3400930181607Commercialized according to BDPM
- 28 capsules, CIP 3400930181621Commercialized according to BDPM
- 7 capsules, CIP 3400930181645Commercialized according to BDPM
- 28 capsules, CIP 3400930181669Commercialized according to BDPM
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.